Navigation Links
CryoCath Arctic Front(R) Results Published in JACC
Date:7/22/2008

- Strong efficacy results from a multi-center 293-patient European

trial -

http://www.cryocath.com

Toronto Stock Exchange Symbol: CYT

MONTREAL, July 22 /PRNewswire-FirstCall/ - CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today announced that results previously presented from three European study centers using the Company's lead product, Arctic Front(R), were published earlier today in the Journal of the American College of Cardiology (JACC).

The peer-reviewed article entitled, 'Circumferential Pulmonary Vein Isolation with the Cryoballoon Technique', appears in the July 22nd edition of JACC and is available online at http://content.onlinejacc.org. It discusses the three-center trial in which 74 percent of the 293 paroxysmal AFib patients enrolled were AFib free and off anti-arrhythmic drugs (AADs) after only one procedure with Arctic Front upon a median follow-up time of 12 months.

"As we continue to increase our market share in Europe, this article adds to the growing body of evidence that is creating a very clear picture of Arctic Front's clinical potential as a simple, safe and effective treatment for paroxysmal AFib," said Jan Keltjens, President and CEO of CryoCath. "Ensuring physicians have access to tangible scientific evidence on the benefits of Arctic Front is part of our strategy to drive product adoption and build upon the strong base of business we have already established."

The study, conducted in Germany, was led by Dr. Vogt from the Herz und Diabetes Zentrum NRW in Bad Oeynhausen, Prof. Dr. Schumacher from Herz- und Gefss-Klinik in Bad Neustadt and Dr. Pitschner from the Kerckhoff-Klinik in Bad Nauheim.

The patients enrolled in the 346-person study were predominantly paroxysmal AFib sufferers (n=293) with a small group of p
'/>"/>

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Monday, August ... will lead the call.  Date:Monday, ... 507-2598Pass Code: 68380312 Webcast, including Replay and ...
(Date:7/27/2015)... July 27, 2015 As per the ... - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... 7.96 billion in 2014, growing at a CAGR of 13.2% ... in 2021. The global bionics market is growing ... which is leading to paralysis or amputation of body parts. ...
(Date:7/27/2015)... , July 20, 2015 Research and ... the "Medical Device Regulation in Asia/Pacific Markets Seminar" ... that the European Medical Device market is well established, ... . China , together with other ... in the process of implementing, their own medical device ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... Advances and Expands Internal Pipeline as DARA Program Enters ... Development and New SARM Program is Added, PRINCETON, ... for the quarter and nine months ended,September 30, 2007, ... corporate milestones achieved since the beginning,of the quarter. ...
... Laboratories, Inc.,(NYSE: FRX ) today announced ... trial, published in the November 2007 issue ... that nebivolol,significantly reduced sitting diastolic and systolic ... with stage I-II hypertension.,The study also found ...
Cached Medicine Technology:Pharmacopeia Announces Third Quarter 2007 Financial Results 2Pharmacopeia Announces Third Quarter 2007 Financial Results 3Pharmacopeia Announces Third Quarter 2007 Financial Results 4Pharmacopeia Announces Third Quarter 2007 Financial Results 5Pharmacopeia Announces Third Quarter 2007 Financial Results 6Pharmacopeia Announces Third Quarter 2007 Financial Results 7Pharmacopeia Announces Third Quarter 2007 Financial Results 8Pharmacopeia Announces Third Quarter 2007 Financial Results 9Pharmacopeia Announces Third Quarter 2007 Financial Results 10Pharmacopeia Announces Third Quarter 2007 Financial Results 11UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 2UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 3
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... today, especially in wound center management. Earlier this year Wound Care Advantage ... education and training for WCA wound centers. Customized learning paths allow for ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published July ... of plastic surgery and explained why people should not shy away from their own ... excesses of the few and celebrate it for the modern wonder that it is.” ...
(Date:7/27/2015)... ... ... North Central Surgical Center Hospital will be holding twice-monthly joint wellness classes ... patients, along with their friends and family members, to attend. The classes take place ... 8 [Tue due to Labor Day], Oct 5, Nov 2, Dec 7) beginning at ...
(Date:7/27/2015)... ... ... A Harris County jury awarded a group of Texas and Canadian investors approximately ... on findings of fraud and violations of the Texas Securities Act. The verdict was ... 2010-09675; Jo Ann Schermerhorn, et al v. CenturyLink, Inc. and Robert Kubbernus, et al., ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... To Reduce Hospital Readmissions." , The Centers for Medicare and Medicaid Services (CMS) ... as part of their penalty calculation. Known as the QualityNet Hospital-Specific Report (HSR), ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 3Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 4Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 5Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 6Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2
... On the eve of President Obama,s healthcare summit ... said today that expanding and updating Medicare to ... approach to achieving the goals and principles outlined ... Congress and budget proposal.While welcoming President Obama,s call ...
... University Baptist Medical Center, and colleagues, have identified a ... people with cystic fibrosis, a lethal genetic condition. The ... treatment, researchers say. , The study appeared online last ... . It is the first published study to search ...
... IDIX ) announced today that management will present ... Conference on Tuesday, March 10th at 1:30 p.m. ET at ... Company 29th Annual Healthcare Conference on Tuesday , March ... Marriott Copley Place.The live and archived webcasts of the presentations ...
... WXYZ is proud to announce that ... Nielsen , will now be seen exclusively on Channel ... 15 years Peter Nielsen has hosted the nationally syndicated ... author of numerous books and videos on health and fitness and is ...
... Genaera Corporation (Nasdaq: GENR ) today announced its financial ... net loss for the year ended December 31, 2008 was $16.0 ... a net loss of $15.7 million, or $(0.90) per share basic ... loss for the quarter ended December 31, 2008 was $3.6 million, ...
... percent increased chance of death, rehospitalization , , TUESDAY, March ... blood thinner Plavix, plus a proton pump inhibitor such ... of death or another heart attack, a new study ... help reduce the risk of another heart attack after ...
Cached Medicine News:Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 2Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 3Health News:Scientists find gene that modifies severity of cystic fibrosis lung disease 2Health News:Scientists find gene that modifies severity of cystic fibrosis lung disease 3Health News:Peter Nielsen Has a New Home on WXYZ-TV! 2Health News:Genaera Corporation Announces 2008 Financial Results 2Health News:Genaera Corporation Announces 2008 Financial Results 3Health News:Genaera Corporation Announces 2008 Financial Results 4Health News:Genaera Corporation Announces 2008 Financial Results 5Health News:Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack 2Health News:Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack 3
CHEMICON's Advanced Tissue Arrayer with patent-pending technology allows you to create customized arrays of multiple tissu specimens on a single slide, saving time and money....
CO2 gas object holder and knife freezer for the 8000 Series Sliding Microtome...
Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen....
... 5040 microtome is of rotary retracting, self-lubricating design ... cutting arm. Its robust construction makes it accurate ... hinges means that all lateral motion is controlled ... be experienced in other, lesser designs which can ...
Medicine Products: